1. Home
  2. EXPI vs NAMS Comparison

EXPI vs NAMS Comparison

Compare EXPI & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPI
  • NAMS
  • Stock Information
  • Founded
  • EXPI 2008
  • NAMS 2019
  • Country
  • EXPI United States
  • NAMS Netherlands
  • Employees
  • EXPI N/A
  • NAMS N/A
  • Industry
  • EXPI Real Estate
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXPI Finance
  • NAMS Health Care
  • Exchange
  • EXPI Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • EXPI 2.2B
  • NAMS 2.3B
  • IPO Year
  • EXPI N/A
  • NAMS N/A
  • Fundamental
  • Price
  • EXPI $13.25
  • NAMS $20.12
  • Analyst Decision
  • EXPI Hold
  • NAMS Strong Buy
  • Analyst Count
  • EXPI 2
  • NAMS 6
  • Target Price
  • EXPI $13.50
  • NAMS $33.80
  • AVG Volume (30 Days)
  • EXPI 818.9K
  • NAMS 634.7K
  • Earning Date
  • EXPI 11-07-2024
  • NAMS 11-06-2024
  • Dividend Yield
  • EXPI 1.52%
  • NAMS N/A
  • EPS Growth
  • EXPI N/A
  • NAMS N/A
  • EPS
  • EXPI N/A
  • NAMS N/A
  • Revenue
  • EXPI $4,458,228,000.00
  • NAMS $33,594,000.00
  • Revenue This Year
  • EXPI $8.76
  • NAMS N/A
  • Revenue Next Year
  • EXPI $7.62
  • NAMS N/A
  • P/E Ratio
  • EXPI N/A
  • NAMS N/A
  • Revenue Growth
  • EXPI 5.50
  • NAMS 78.77
  • 52 Week Low
  • EXPI $8.91
  • NAMS $8.90
  • 52 Week High
  • EXPI $17.11
  • NAMS $26.35
  • Technical
  • Relative Strength Index (RSI)
  • EXPI 47.87
  • NAMS 44.60
  • Support Level
  • EXPI $12.32
  • NAMS $19.59
  • Resistance Level
  • EXPI $14.85
  • NAMS $25.32
  • Average True Range (ATR)
  • EXPI 0.80
  • NAMS 1.44
  • MACD
  • EXPI -0.13
  • NAMS -0.32
  • Stochastic Oscillator
  • EXPI 32.07
  • NAMS 36.35

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: